Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study

Abstract

A small proportion of patients with psoriasis treated with biologics are either super-responders or treatment refractory. Treatment refractory patients have higher body weight, whereas super-responders have fewer comorbidities and higher socioeconomic status.